Special Issues

  • HOME
  • Special Issues
  • Special issue
Interactions between metabolic phenotypes and chronic liver diseases

Topic: Interactions between metabolic phenotypes and chronic liver diseases

Guest Editor: Dae Won Jun, M.D.
Department of Internal Medicine, Hanyang University Seoul Hospital

Special Issue Introduction
This special issue of CMH, entitled “Interactions between Metabolic Phenotypes and Chronic Liver Diseases,” includes a selection of recent research topics and current review articles in the field of fatty liver disease itself, as well as the associated other liver diseases with metabolic dysfunction. Metabolic associated fatty liver disease (MAFLD) may either be genetic or strongly associated with the metabolic syndrome. We are interested in the effects of diet, microbiome, genetics, and sarcopenia on the development of MAFLD. In addition, we are also very interested in screening a high-risk group of MAFLD from the general population and establishing a referral pathway in primary care settings. Currently, we are waiting for the data on the effect of fatty liver or metabolic dysfunction on the clinical course in pre-existing liver diseases.

Submission Information
For Special issue guidelines, please refer to https://www.e-cmh.org/special/guidelines.php
For Author Instructions, please refer to https://www.e-cmh.org/authors/authors.php
For Online Submission, please login at https://mc04.manuscriptcentral.com/cmh
Contacts: Han Ah Lee, Associate editor, amelia86@naver.com

Original Article
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
Clin Mol Hepatol. 2022;28(3):483-496.   Published online March 2, 2022
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2022;28(4):841-850.   Published online September 19, 2022

Clinical and

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
TODAY : 797
TOTAL : 1680027
Close layer